Galectin-3 cleavage as a marker for matrix metalloproteinase activity in cancer

Provided are differential antibodies recognizing the cleaved and non-cleaved forms of matrix metalloproteinases (MMPs), and methods of using the antibodies as surrogate diagnostic markers for the presence of active MMPs in cancer, such as growing breast cancers.

Attached files:
US 20090269779.jpg

Patents:
US 20,090,269,779

Inventor(s): RAZ AVRAHAM [US]; NANGIA-MAKKER PRATIMA [US]; FRIDMAN RAFAEL [US]

Type of Offer: Licensing



Next Patent »
« More Biotech Patents

Share on      


CrowdSell Your Patent